Search results | NICE

2 results

Sorted by Relevance . Sort by Date

Guidance Remove Guidance filter
NICE Pathways Remove NICE Pathways filter
Last 6 months Remove Last 6 months filter
Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
Safe staffing guidelines Remove Safe staffing guidelines filter
Public health guidelines Remove Public health guidelines filter
COVID-19 NHSE/I specialty guides Remove COVID-19 NHSE/I specialty guides filter

Volanesorsen for treating familial chylomicronaemia syndrome (HST13)

Evidence-based recommendations on volanesorsen (Waylivra) for treating familial chylomicronaemia syndrome in adults

Type

Highly specialised technologies guidance

Published

21 October 2020
View recommendations for HST13

Show all sections for HST13
Sections for HST13

Overview

1 Recommendations

2 The condition

3 The technology

4 Consideration of the evidence

5 Implementation

6 Evaluation committee members and NICE project team
Metreleptin for treating lipodystrophy (HST14)

Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults

Type

Highly specialised technologies guidance

Published

24 February 2021
View recommendations for HST14

Show all sections for HST14
Sections for HST14

Overview

1 Recommendations

2 The condition

3 The technology

4 Consideration of the evidence

5 Implementation

6 Evaluation committee members and NICE project team